Latest News
Breaking news and real-time updates from the ASX small-cap market
Visionflex Wins A$0.8m NSW Health Hardware Contract
Visionflex (ASX:VFX) wins A$0.8m NSW Health RPM hardware contract, signaling near-term revenue visibility as it pivots to recurring software revenue.
Canyon Resources Advances Minim Martap Logistics with Cameroon Locomotive Delivery
Canyon Resources advances Minim Martap logistics with Cameroon locomotive delivery, targeting first bauxite shipment by year-end and stronger rail capacity.
Chilwa Minerals Enhances Mposa Mineral Sands Deposit with REE Mineralisation
Chilwa Minerals reports widespread REE in clays beneath Mposa HMS, Malawi; TREO ~525ppm avg (peak 987ppm). ANSTO desorption tests gauge recoveries.
Solstice Minerals Extends Nanadie Copper-Gold System at Depth
Solstice Minerals extends Nanadie copper-gold system with 629.1m at 0.50% Cu and 0.17 g/t Au in diamond tail, expanding beyond MRE; Phase 2 drilling underway.
CZR Resources and Zuleika Gold Propose All-Scrip Merger of WA Assets
CZR Resources and Zuleika Gold unveil all-scrip WA merger; Zuleika valued at A$44.8m, 32.9% premium; boards unanimously back off-market deal.
Elixir Energy Completes Fracture Stimulation Program at Lorelle-3H Appraisal Well
Elixir Energy completes 12-stage fracture stimulation at Lorelle-3H; flow-back and 30-day gas-condensate production test to gauge commercial potential.
Renascor Resources Identifies Large-Scale Copper Potential at Flat Hill
Renascor flags district-scale copper potential at Flat Hill after review shows widespread mineralisation; plans re-assays, VTEM survey, and new drill targets.
Australian Rare Earths Confirms Koppamurra Economics And Maiden Ore Reserve with PFS
Australian Rare Earths' Koppamurra PFS: A$858m NPV, 99% IRR, 0.9yr payback; maiden ore reserve 26 Mt at 920ppm TREO; A$178m capex.
Racura Oncology Treats First Patient in Harness-1 EGFRm Lung Cancer Trial
Racura Oncology starts Harness-1 Phase 1 with first patient dosed for RC220 + osimertinib in EGFR-mutant NSCLC; early safety data awaited.
Inoviq Announces Rapid Tumour-Killing Activity in Study of CAR-Exosomes on Ovarian Cancer Cells
Inoviq CAR-exosomes show rapid in vitro ovarian cancer killing, ~90% in OVCAR-3/Caov-3 within 48 hours, eyeing first-in-human trials by 2028.
Orcoda Signs Multi-Year Logistics Contract with Wellcamp Accommodation
Orcoda seals multi-year $8m/yr logistics deal with Wellcamp Accommodation, using Contractor360 AI platform; growth upside in mining, resources.
Echo IQ and Pro Medicus Join Forces to Market Echosolv Cardiac Platform to US Healthcare Sector
Echo IQ and Pro Medicus announce up to $20m investment to market EchoSolv HF AI cardiac platform in the US; reseller deal to accelerate adoption.